HAE-话题@MedSci

#HAE#

411篇内容 | 2343人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2008405, encodeId=9a09200840503, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, objectType=article, longId=158333, objectId=632d1583337f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=632d1583337f, replyNumber=0, likeNumber=97, createdTime=2019-04-09, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=632d1583337f, moduleTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=632d1583337f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008400, encodeId=aa0f2008400fa, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：缺血性卒中患者使用糖皮质激素心血管事件风险知多少, objectType=article, longId=155424, objectId=5a66155424ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a66155424ee, replyNumber=0, likeNumber=65, createdTime=2019-02-25, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a66155424ee, moduleTitle=J Thromb Haemost：缺血性卒中患者使用糖皮质激素心血管事件风险知多少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a66155424ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008419, encodeId=c7fa200841915, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haemat：多发性骨髓瘤患者进行自体造血细胞移植前的预处理, objectType=article, longId=164440, objectId=fa3a164440b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa3a164440b4, replyNumber=0, likeNumber=67, createdTime=2019-10-30, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa3a164440b4, moduleTitle=Lancet haemat：多发性骨髓瘤患者进行自体造血细胞移植前的预处理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa3a164440b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008424, encodeId=f7ef20084242f, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematology.：Guadecitabine用于中高危骨髓增生异常综合征, objectType=article, longId=165485, objectId=0adb1654850e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0adb1654850e, replyNumber=0, likeNumber=72, createdTime=2019-11-16, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0adb1654850e, moduleTitle=Lancet Haematology.：Guadecitabine用于中高危骨髓增生异常综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0adb1654850e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008381, encodeId=7b6b200838119, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Brit J Haematol：R/R-AML患者 HSCT前用高剂量美法仑更有利？, objectType=article, longId=144794, objectId=13f5144e942c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13f5144e942c, replyNumber=0, likeNumber=64, createdTime=2018-12-05, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13f5144e942c, moduleTitle=Brit J Haematol：R/R-AML患者 HSCT前用高剂量美法仑更有利？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13f5144e942c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008373, encodeId=a91520083e349, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet haemat：利妥昔单抗可显著降低滤泡性淋巴瘤向侵袭性淋巴瘤转化的风险, objectType=article, longId=142572, objectId=f2021425e29a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2021425e29a, replyNumber=0, likeNumber=70, createdTime=2019-06-01, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2021425e29a, moduleTitle=Lancet haemat：利妥昔单抗可显著降低滤泡性淋巴瘤向侵袭性淋巴瘤转化的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2021425e29a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008394, encodeId=c501200839441, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：Avatrombopag增加肝脏疾病所致的血小板减少症患者血小板计数但不增加血小板活化, objectType=article, longId=150227, objectId=262115022ecf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=262115022ecf, replyNumber=0, likeNumber=77, createdTime=2019-02-22, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=262115022ecf, moduleTitle=J Thromb Haemost：Avatrombopag增加肝脏疾病所致的血小板减少症患者血小板计数但不增加血小板活化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=262115022ecf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008386, encodeId=38e820083866a, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：华法林治疗稳定患者，实施延长INR检测间隔可行吗, objectType=article, longId=146689, objectId=364f14668934, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=364f14668934, replyNumber=0, likeNumber=60, createdTime=2019-04-17, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=364f14668934, moduleTitle=J Thromb Haemost：华法林治疗稳定患者，实施延长INR检测间隔可行吗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=364f14668934)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008412, encodeId=3d002008412bb, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：预防VTE患者复发性VTE和大出血：阿哌沙班vs利伐沙班, objectType=article, longId=161612, objectId=56ae16161288, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56ae16161288, replyNumber=0, likeNumber=72, createdTime=2019-03-20, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56ae16161288, moduleTitle=Lancet Haematol：预防VTE患者复发性VTE和大出血：阿哌沙班vs利伐沙班, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56ae16161288)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008361, encodeId=cd49200836185, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Haematologica：新诊断AML的老年患者：三种疗法一较高下, objectType=article, longId=137654, objectId=472e13e65413, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=472e13e65413, replyNumber=0, likeNumber=49, createdTime=2018-07-22, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=472e13e65413, moduleTitle=Haematologica：新诊断AML的老年患者：三种疗法一较高下, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=472e13e65413)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008370, encodeId=c4be20083e09a, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Br J Haematol：既往未治疗的低级别淋巴瘤患者：这三个药联合获得较高应答率, objectType=article, longId=141181, objectId=358114118169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=358114118169, replyNumber=0, likeNumber=168, createdTime=2018-09-13, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=358114118169, moduleTitle=Br J Haematol：既往未治疗的低级别淋巴瘤患者：这三个药联合获得较高应答率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=358114118169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008380, encodeId=c50c20083802b, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Haematologica：鲁索利替尼治疗晚期复发/难治性霍奇金淋巴瘤效果如何？, objectType=article, longId=144692, objectId=895114469266, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=895114469266, replyNumber=0, likeNumber=96, createdTime=2018-11-16, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=895114469266, moduleTitle=Haematologica：鲁索利替尼治疗晚期复发/难治性霍奇金淋巴瘤效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=895114469266)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008366, encodeId=6785200836657, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematology:解锁更多血型，准确率超99% ！基因组测序下的输血新时代来临, objectType=article, longId=139114, objectId=6780139114a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6780139114a0, replyNumber=0, likeNumber=0, createdTime=2018-11-01, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6780139114a0, moduleTitle=Lancet Haematology:解锁更多血型，准确率超99% ！基因组测序下的输血新时代来临, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6780139114a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008389, encodeId=a8c0200838941, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Br J Haematol：开始治疗时间也是侵袭性非霍奇金淋巴瘤的独立预后因素？, objectType=article, longId=146869, objectId=030e146869df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=030e146869df, replyNumber=0, likeNumber=84, createdTime=2019-03-02, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=030e146869df, moduleTitle=Br J Haematol：开始治疗时间也是侵袭性非霍奇金淋巴瘤的独立预后因素？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=030e146869df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008396, encodeId=b8eb2008396e5, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Lancet Haematol：老年AML新的低强度方案：克拉屈滨+低剂量阿糖胞苷交替地西他宾, objectType=article, longId=152647, objectId=6ddf15264e3b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ddf15264e3b, replyNumber=0, likeNumber=76, createdTime=2018-11-27, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ddf15264e3b, moduleTitle=Lancet Haematol：老年AML新的低强度方案：克拉屈滨+低剂量阿糖胞苷交替地西他宾, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ddf15264e3b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008393, encodeId=109e20083930f, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Haematologica：TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子, objectType=article, longId=148690, objectId=adeb1486905b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adeb1486905b, replyNumber=0, likeNumber=58, createdTime=2019-04-26, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adeb1486905b, moduleTitle=Haematologica：TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adeb1486905b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008351, encodeId=58bc200835197, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Br J Haematol：利妥昔单抗诱导治疗无症状滤泡性淋巴瘤省钱又有效？, objectType=article, longId=130821, objectId=fe7113082182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe7113082182, replyNumber=0, likeNumber=35, createdTime=2018-05-05, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe7113082182, moduleTitle=Br J Haematol：利妥昔单抗诱导治疗无症状滤泡性淋巴瘤省钱又有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe7113082182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008350, encodeId=8bde200835028, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, objectType=article, longId=130819, objectId=73341308194e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73341308194e, replyNumber=0, likeNumber=70, createdTime=2019-01-12, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73341308194e, moduleTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73341308194e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008397, encodeId=c1d4200839eb8, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=SPSS实战：两个有序分类变量的趋势检验（Mantel-Haenszel卡方检验）, objectType=article, longId=152962, objectId=3a7b152962b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a7b152962b6, replyNumber=0, likeNumber=73, createdTime=2019-04-13, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a7b152962b6, moduleTitle=SPSS实战：两个有序分类变量的趋势检验（Mantel-Haenszel卡方检验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a7b152962b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2008384, encodeId=ab10200838477, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, objectTitle=J Thromb Haemost：透析患者因出血、心肌梗死和卒中导致的死亡率分析, objectType=article, longId=145844, objectId=121214584437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=121214584437, replyNumber=0, likeNumber=70, createdTime=2018-09-03, rootId=0, userName=changfy, userId=32d177, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=121214584437, moduleTitle=J Thromb Haemost：透析患者因出血、心肌梗死和卒中导致的死亡率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=121214584437)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HAE

2020-05-29

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案

2019-04-09

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：缺血性卒中患者使用糖皮质激素心血管事件风险知多少

2019-02-25

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haemat：多发性骨髓瘤患者进行自体造血细胞移植前的预处理

2019-10-30

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematology.：Guadecitabine用于中高危骨髓增生异常综合征

2019-11-16

changfy (审核中...)

前往app查看评论内容

#HAE#

Brit J Haematol：R/R-AML患者 HSCT前用高剂量美法仑更有利？

2018-12-05

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet haemat：利妥昔单抗可显著降低滤泡性淋巴瘤向侵袭性淋巴瘤转化的风险

2019-06-01

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：Avatrombopag增加肝脏疾病所致的血小板减少症患者血小板计数但不增加血小板活化

2019-02-22

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：华法林治疗稳定患者，实施延长INR检测间隔可行吗

2019-04-17

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：预防VTE患者复发性VTE和大出血：阿哌沙班vs利伐沙班

2019-03-20

changfy (审核中...)

前往app查看评论内容

#HAE#

Haematologica：新诊断AML的老年患者：三种疗法一较高下

2018-07-22

changfy (审核中...)

前往app查看评论内容

#HAE#

Br J Haematol：既往未治疗的低级别淋巴瘤患者：这三个药联合获得较高应答率

2018-09-13

changfy (审核中...)

前往app查看评论内容

#HAE#

Haematologica：鲁索利替尼治疗晚期复发/难治性霍奇金淋巴瘤效果如何？

2018-11-16

changfy (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematology:解锁更多血型，准确率超99% ！基因组测序下的输血新时代来临

2018-11-01

changfy (审核中...)

前往app查看评论内容

#HAE#

Br J Haematol：开始治疗时间也是侵袭性非霍奇金淋巴瘤的独立预后因素？

2019-03-02

智者为医08 (审核中...)

前往app查看评论内容

#HAE#

Lancet Haematol：老年AML新的低强度方案：克拉屈滨+低剂量阿糖胞苷交替地西他宾

2018-11-27

changfy (审核中...)

前往app查看评论内容

#HAE#

Haematologica：TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子

2019-04-26

changfy (审核中...)

前往app查看评论内容

#HAE#

Br J Haematol：利妥昔单抗诱导治疗无症状滤泡性淋巴瘤省钱又有效？

2018-05-05

changfy (审核中...)

前往app查看评论内容

#HAE#

Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？

2019-01-12

changfy (审核中...)

前往app查看评论内容

#HAE#

SPSS实战：两个有序分类变量的趋势检验（Mantel-Haenszel卡方检验）

2019-04-13

changfy (审核中...)

前往app查看评论内容

#HAE#

J Thromb Haemost：透析患者因出血、心肌梗死和卒中导致的死亡率分析

2018-09-03

科室
- - 订阅+
  - 更多科室
工具
服务